Methods for target molecule detection using siderophores and related compositions
CA 2565844 C · Owner: Perkinelmer Health Sciences, Inc. · Inventors: Bosse, Roger; Patton, Wayne F.; Roby, Philippe
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides methods for isolating a target molecule from a sample. In an embodiment, the method involves contacting a sample with a capture agent, the agent comprising a siderophore and a transition metal cation under , conditions wherein the agent is capable of binding a target molecule to form a target molecule-capture agent complex, wherein the target molecule is selected from the group consisting of a phosphorylated molecule a nitrotyrosine-, containing molecule and a sulfated molecule and separating the target , molecule-capture agent complex from the sample thereby isolating the target , molecule from the sample. Also provided are methods for determining the presence …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 9, 2005 and granted August 11, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 9, 2025.
- Certificates of supplementary protection extend only drug patents, and it isn't classified as one.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.